Why the study?
Does revascularization prevent stroke in patients with asymptomatic carotid artery stenosis?
Does revascularization prevent stroke in patients with asymptomatic carotid artery stenosis?
This review summarizes factors for clinical decision-making between medical therapy and revascularization for asymptomatic carotid artery stenosis, noting that modern medical therapy has reduced stroke rates to approximately 1% per year.
May warrant deferring revascularization in asymptomatic carotid stenosis; leaves open whether new trials are needed versus modern medical therapy.
Optimal management of patients with asymptomatic carotid artery stenosis remains unclear. Although 2 high-quality randomized clinical trials demonstrated reductions in ispsilateral stroke rates in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic carotid artery stenosis has reduced rates of stroke to approximately 1% per year, raising questions about the generalizability of these previous trials to current medical practice. However, reductions in adverse events after revascularization can make revascularization more attractive. The emergence of percutaneous revascularization for carotid artery stenosis has raised further questions about optimal management of asymptomatic carotid artery stenosis. This Grand Rounds summarizes the factors to consider when counseling patients and making clinical decisions regarding medical therapy and revascularization for patients with asymptomatic carotid artery stenosis. This information should provide clinicians with the knowledge base to counsel patients about the risks and benefits of treatment options.
No takes yet. Share an insight, caveat, or question.
Joshua A. Beckman (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: